Association between insulin resistance and endothelial dysfunction in renal transplant recipients

Clinical Transplantation

Volumn 20, Issue 2, 2006, Pages 195-199

  Voytovich, Monica Hagen ^a   Åsberg, Anders ^a   Hjelmesæth, Jøran ^a   Jenssen, Trond ^a   Hartmann, Anders ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Endothelial function; Insulin resistance; Renal transplantation

Indexed keywords

ACETYLCHOLINE; AZATHIOPRINE; CYCLOSPORIN A; ENDOTHELIN 1; GLUCOSE; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; PREDNISOLONE; TACROLIMUS; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; ENDOTHELIAL DYSFUNCTION; FEMALE; FUNCTIONAL ASSESSMENT; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; NON INVASIVE MEASUREMENT; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN STIMULATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BLOOD GLUCOSE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NITRIC OXIDE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; VASOCONSTRICTION; VASODILATION;

EID: 33646043433     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00465.x     Document Type: Article

References (23)

1. Morris ST, McMurray JJ, Rodger RS, Farmer R, Jardine AG. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 2000: 57: 1100.
2. Hausberg M, Kisters K, Kosch M, Rahn KH, Barenbrock M. Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients. Kidney Int 1999: 55: 1104.
3. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000: 101: 1899.
4. Yki-Jarvinen H. Insulin resistance and endothelial dysfunction. Best Pract Res Clin Endocrinol Metab 2003: 17: 411.
5. Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A. Insulin resistance after renal transplantation: Impact of immunosuppressive and antihypertensive therapy. Diabetes Care 2001: 24: 2121.
6. Hjelmesaeth J, Hartmann A, Kofstad J et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997: 64: 979.
7. Asberg A, Holm T, Vassbotn T, Andreassen AK, Hartmann A. Nonspecific microvascular vasodilation during iontophoresis is attenuated by application of hyperosmolar saline. Microvasc Res 1999: 58: 41.
8. Voytovich MH, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A. Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. Nephrol Dial Transplant 2005: 20: 413.
9. Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant 2003: 18: 2154.
10. Asberg A, Holdaas H, Fjeldsa E, Hartmann A. Atorvastatin improves endothelial function in renal transplant recipients. Nephrol Dial Transplant 2001: 16: 1920.
11. Holm T, Andreassen AK, Ueland T et al. Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients. Am J Cardiol 2001: 87: 815.
12. Asberg A, Holdaas H, Jardine AG, Edvardsen C, Hartmann A. Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation. Clin Transplant 2003: 17: 385.
13. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem 1995: 41: 892.
14. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000: 23: S4.
15. Hsueh WA, Quiñones MJ. Role of endothelial dysfunction in insulin resistance. Am J Cardiol 2003: 92: 10J.
16. Asberg A, Midtvedt K, Vassbotn T, Hartmann A. Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients. Nephrol Dial Transplant 2001: 16: 1465.
17. Asberg A, Berg KJ, Hartmann A. Each administration of cyclosporin A enhances skin microvascular reactivity in renal transplant recipients. Microvasc Res 2000: 60: 81.
18. Steinberg HO, Tarshoby M, Monestel R et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997: 100: 1230.
19. Steinberg HO, Baron AD. Vascular function, insulin resistance and fatty acids. Diabetologia 2002: 45: 623.
20. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963: 1: 785.
21. Yki-Jarvinen H, Puhakainen I, Koivisto VA. Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocrinol Metab 1991: 72: 1268.
22. Yki-Jarvinen H, Helve E, Koivisto VA. Hyperglycemia decreases glucose uptake in type 1 diabetes. Diabetes 1987: 36: 892.
23. Morris ST, McMurray JJ, Rodger RS, Farmer R, Jardine AG. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 2000: 57: 1100.